Summary & Overview
CPT 94610: Endotracheal Surfactant Administration
CPT code 94610 covers endotracheal administration of surfactant by a qualified provider, a therapeutic pulmonary procedure used to treat respiratory conditions such as cystic fibrosis. This procedure is an important intervention in acute care, typically performed in hospital inpatient settings or intensive care units where secure airway management is available. Nationally, surfactant administration carries clinical significance for patients with severe respiratory dysfunction and can affect length of stay, ventilator dependence, and resource use.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a national-level view rather than state-specific guidance.
Readers will find a concise explanation of the clinical context and service setting for CPT code 94610, an outline of typical payer considerations, and sections covering common modifiers and coding context where available. The report also highlights benchmarking concepts, coding practice notes, and policy or coverage considerations relevant to hospitals and post-acute providers. Data not available in the input is identified where necessary.
Billing Code Overview
CPT code 94610 describes administration of a surfactant directly into the lungs through an endotracheal tube. The procedure is performed by a provider or other qualified health care professional to treat respiratory conditions such as cystic fibrosis where surfactant replacement is clinically indicated.
Service type: Therapeutic pulmonary procedure — endotracheal surfactant administration
Typical site of service: Hospital inpatient or neonatal/pediatric intensive care unit (ICU) or other acute care setting where endotracheal intubation and airway management are performed.
Clinical & Coding Specifications
Clinical Context
A neonate or infant with respiratory distress and surfactant deficiency is intubated in the neonatal intensive care unit (NICU) or pediatric intensive care unit (PICU) for mechanical ventilation. The clinician prepares and instills exogenous surfactant via the endotracheal tube to improve lung compliance and oxygenation. Typical workflow: assessment of respiratory status and indication (e.g., increasing oxygen requirements, persistent hypoxemia, or radiographic findings consistent with surfactant deficiency), confirmation of airway placement, dosing and preparation of the surfactant medication, brief manual ventilation or ventilator adjustments during instillation, post‑administration suctioning as indicated, and close monitoring of vital signs and blood gases. The procedure is commonly performed by neonatologists, pediatric intensivists, respiratory therapists under direction, or other qualified providers in an ICU setting; it may be billed when the provider performs endotracheal instillation of surfactant for treatment of conditions such as neonatal respiratory distress syndrome or other surfactant-deficient states.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Description not otherwise specified for local use | Data not available in the input. |
11 |